PACIFIC BIOSCIENCES OF CALIFORNIA WKN: A1C3EQ ISIN: US69404D1081 Kürzel: PACB Forum: Aktien Thema: Hauptdiskussion

So bin wieder bissl über EK. Jetzt wärs schön wenns mal nach Norden geht 😅

https://www.pacb.com/blog/tackling-a-giant-genome/

Habe gerade von jemanden der Amis erfahren, dass im Conference Call gesagt wurde, dass die Verkauftruppe von 20 auf 40 ab jetzt gesteigert werden soll. In den kommenden Jahren sogar auf 120.

Sie müssen besser sein, sonst gehts ja nicht nach oben. Aber ich hab Zeit. Ich hätte gerne 30 Euro in 3-5 Jahren. Ist möglich wenn sie das abliefern was sie versprechen...

Die Zahlen sind noch ka.cke. Sollte aber die nächsten zwei Jahre besser werden.

😬 an den Zahlen müssen wir noch arbeiten 😅

Pacific Biosciences of California (NASDAQ:PACB): Q3 GAAP EPS of -$0.14 in-line. Revenue of $19.08M (-13.0% Y/Y) misses by $1.25M. Shares -5.66%.

😊👍

"It is an exciting time to join Pacific Biosciences," said Christian Henry. "Our newly launched Sequel IIe instrument will make the use of our long-read technology accessible to more customers than ever before. In addition, HiFi sequencing provides researchers with more complete and accurate sequences, which is one reason why we are engaging in so many important customer collaborations. With the positive customer momentum building around PacBio HiFi sequencing, we expect sequential growth for Q4. Notwithstanding capital sales being impacted in the near term as a result of the COVID-19 pandemic, we continue to be enthusiastic about the long-term growth opportunity for the business."

https://www.pacb.com/smrt-science/smrt-sequencing/

https://www.pacb.com/videos/video-poster-capture-long-read-isoform-sequencing-iso-seq-for-uncovering-human-isoform-diversity-in-the-brain-and-characterizing-sars-cov2-viral-rnas/?platform=hootsuite&utm_campaign=Twitter

Very exciting week for @PacBio in the UK, the first Sequel IIe system has arrived at @OxfordGenomics . The very first time that SMRT Sequencing and #HiFiReads will be available in Oxford. Congratulations to the team at OGC!

We're pleased to be working alongside @PacBio and @ChildrensMercy to use #Azure, AI, and cutting-edge technologies to understand the genetic causes of rare diseases in children:  Children’s Mercy Kansas City Teams Up with Pacific Biosciences to Fight Rare Disease globenewswire.com

Invitae and PacBio https://www.stocktitan.net/news/PACB/invitae-and-pacific-biosciences-collaborate-to-develop-whole-genome-8oatrmo6xx0u.html#

https://finance.yahoo.com/news/pacific-biosciences-unveils-sequel-iie-153003747.html?guccounter=1

https://mobile.twitter.com/PacBio/status/1318902134419619842